How do cancer cells evade the immune system, growing undetected until they’re discovered as a tumor?
[OneMedForum] Alexza Pharmaceuticals’ Pipeline Is Built for Speed
Alexza Pharmaceuticals of Mountain View, Calif., is focused on the development of inhalation drugs for the treatment of central nervous system disorders.
[OneMedForum] Senesco Technologies: Life and Death on a Cellular Level
“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process.
[OneMedForum] Micrus Endovascular: Help for Stroke Patients
Micrus Endovascular is the only publicly traded company focused on strokes.
Diabetes Drug Wins Approval, Helps the Competition
The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.
Genomic Health’s Colon Cancer Test Goes Worldwide
Genomic Health, a developer of genomics-based diagnostic tests, announced on Thursday the worldwide availability of its Oncotype DX Colon Cancer Test.
[OneMedForum] NuVue Therapeutics’ Multi-Step Approach to Cancer Therapy
NuVue Therapeutics is commercializing a site-specific regimen of cancer therapy for soft tissue tumors.
Enzon and Sopherion Make Breast Cancer Progress
Two biopharmaceutical companies took a step forward this week with their pipelines for advanced breast cancer.
